Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
11/07/2002 | US20020164772 Multiple drug resistance gene atrD of aspergillus nidulans |
11/07/2002 | US20020164771 Methods for lyophilizing competent cells |
11/07/2002 | US20020164770 DNA transfection system for the generation of infectious influenza virus |
11/07/2002 | US20020164768 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of thrombosis and vascular system disorders |
11/07/2002 | US20020164767 DNA encoding the human serine protease C-E |
11/07/2002 | US20020164763 84241, a novel human ring finger family member and uses thereof |
11/07/2002 | US20020164761 Nucleotide sequences coding polypeptide for use in the treatment and prevention of bacterial propagation |
11/07/2002 | US20020164753 Enzymatic polypeptide for use as tools in genetic engineering |
11/07/2002 | US20020164749 Enzymatic polypeptide for use in the diagnosis and treatment of tumors |
11/07/2002 | US20020164748 Enzymatic polypeptide for use in the treatment of inflammation, autoimmune and tissue rejection disorders |
11/07/2002 | US20020164747 Gene cluster for ramoplanin biosynthesis |
11/07/2002 | US20020164742 DNA encoding methymycin and pikromycin |
11/07/2002 | US20020164738 Cell death inhibitory protein |
11/07/2002 | US20020164734 Human pelota homolog |
11/07/2002 | US20020164732 Polypeptide for use in the treatment and prevention of viral infection |
11/07/2002 | US20020164729 Generating polyhydroxyalkanoates; obtain genetically engineered microorganism which expresses preferential enzymes, incubate with butane, hexane, propane, ethane or pentanediol, culture and recover hydroxyalkanoates |
11/07/2002 | US20020164728 Process for preparing 4-cyanopentanoic acid |
11/07/2002 | US20020164727 Nucleotide sequences coding polypeptide for use as tool in genetic engineering |
11/07/2002 | US20020164720 Generating 2'-deoxyribonucleoside; obtain microorganism, transform with vector containing ribonucleotide reductase, express vector, incubate with substrate, recover 2'-deoxyribonucleoside |
11/07/2002 | US20020164719 Targeting pharmaceutical agents to injured tissues |
11/07/2002 | US20020164715 Nucleotide seqences coding polypeptides for use in the treatment and diagnosis of cancer |
11/07/2002 | US20020164714 Nucleotie sequences coding polypeptide for use in the treatment of reproductive disorders |
11/07/2002 | US20020164707 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer, arthrits, pain, diabetes, migraine and inflammation, hypercalcemia, obesity, hypertension, and bone defects |
11/07/2002 | US20020164704 Novel human monocyte chemotactic proprotein |
11/07/2002 | US20020164702 Nucleotide sequences coding polypeptide for use in the treatment of muscular disorders |
11/07/2002 | US20020164700 Metabolic rate shifts in fermentations expressing recombinant proteins |
11/07/2002 | US20020164698 Identification of Bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction |
11/07/2002 | US20020164692 Immune system-related polynucleotides, polypeptides, and antibodies |
11/07/2002 | US20020164691 Human vomeronasal receptor-5 |
11/07/2002 | US20020164690 Receptor based antagonists and methods of making and using |
11/07/2002 | US20020164688 Membrane associated protein zupar1 |
11/07/2002 | US20020164682 Mammalian cerberus-like protein and compositions |
11/07/2002 | US20020164677 High-throughput microbial culturing |
11/07/2002 | US20020164675 Methods of propagating and detecting infectious forms of intracellular pathogenic microorganisms |
11/07/2002 | US20020164674 Expression vector for use as diagnostic tool in genetic engineering |
11/07/2002 | US20020164668 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
11/07/2002 | US20020164646 Nucleotide sequences coding polypeptide for use in the treatment and prevention of Inflammation, tumors, immunological, inflammatory bowel and crohn's disease |
11/07/2002 | US20020164640 MyD88 adapter-like proteins |
11/07/2002 | US20020164637 Detecting receptor binding ligands; obtain cell extract, incubate with modulator, detect binding, monitor activity from receptor |
11/07/2002 | US20020164603 DNAs and proteins or peptides specific to bacteria of the species Neisseria meningitidis, processes for obtaining them and their biological uses |
11/07/2002 | US20020164600 PD-L2 molecules: novel PD-1 ligands and uses therefor |
11/07/2002 | US20020164591 Enzymatic polypeptide for use in determining biopolymer sequences |
11/07/2002 | US20020164351 External compositions for skin comprising sphingoglycolipid |
11/07/2002 | US20020164305 Integrin fusion protein; binding to antibodies |
11/07/2002 | CA2446023A1 Cell adhesion and extracellular matrix proteins |
11/07/2002 | CA2446010A1 Production of the lantibiotic cinnamycin with genes isolated from streptomyces cinnamoneus |
11/07/2002 | CA2446003A1 Concentration and purification of analytes using electric fields |
11/07/2002 | CA2445978A1 Antigens of group b streptococcus and corresponding dna fragments |
11/07/2002 | CA2445596A1 Method for replicating the hepatitis c virus |
11/07/2002 | CA2445338A1 G-protein coupled receptors |
11/07/2002 | CA2444973A1 Process for producing coenzyme q10 |
11/07/2002 | CA2444911A1 Fusion molecules and methods for treatment of immune diseases |
11/07/2002 | CA2440775A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
11/06/2002 | EP1254959A2 Method for producing cytosine nucleoside compounds |
11/06/2002 | EP1254956A2 Novel osteoinductive compositions |
11/06/2002 | EP1254369A2 Cells expressing zinc finger protein for drug discovery |
11/06/2002 | EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides |
11/06/2002 | EP1254268A1 Methods and materials relating to leucine-rich repeat protein-like (lrr protein-like) polypeptides and polynucleotides |
11/06/2002 | EP1254266A1 Methods and materials relating to alpha-2-macroglobulin-like polypeptides and polynucleotides |
11/06/2002 | EP1254265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides |
11/06/2002 | EP1254264A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
11/06/2002 | EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies |
11/06/2002 | EP1254250A1 Method for the evaluation of implantable materials |
11/06/2002 | EP1254248A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254246A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
11/06/2002 | EP1254245A1 Regulated expression of plac in staphylococcus aureus |
11/06/2002 | EP1254244A2 Manufacture of five-carbon sugars and sugar alcohols |
11/06/2002 | EP1254243A1 Transgenic cells expressing glucosyltransferase nucleic acids |
11/06/2002 | EP1254242A1 17 human secreted proteins |
11/06/2002 | EP1254241A2 Phosphatases |
11/06/2002 | EP1254240A2 Proteins producing an altered immunogenic response and methods of making and using the same |
11/06/2002 | EP1254239A2 Mammalian secreted group iii phospholipase a2 |
11/06/2002 | EP1254236A2 Drug metabolizing enzymes |
11/06/2002 | EP1254235A2 Drug metabolizing enzymes |
11/06/2002 | EP1254234A1 Haemophilus influenza outer membrane protein and use thereof in vaccination |
11/06/2002 | EP1254233A1 Use of a leptospire protein for preventing and/or diagnosing and/or treating animal and/or human leptospirosis |
11/06/2002 | EP1254232A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
11/06/2002 | EP1254231A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
11/06/2002 | EP1254219A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254218A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254216A2 Improved galactosylation of recombinant glycoproteins |
11/06/2002 | EP1254214A2 Human protein kinases and protein kinase-like enzymes |
11/06/2002 | EP1254175A1 Human cystine knot polypeptide |
11/06/2002 | EP1254173A1 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254172A1 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254166A2 Recombinant production of human histone-1 subtypes and use thereof for therapeutic purposes |
11/06/2002 | EP1254165A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254154A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254153A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254152A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254151A1 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254150A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254147A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1098956B1 Improved device and method for lysis of micro-organisms |
11/06/2002 | EP0909277A3 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods |
11/06/2002 | EP0773959B1 Adrenergic receptor |
11/06/2002 | EP0757720B1 Trimerising polypeptides, their manufacture and use |
11/06/2002 | EP0742816B1 Microorganisms for biological control of plant diseases |
11/06/2002 | CN1378597A Immunogenic polypeptides derived from morazella catarrhalis and uses thereof |
11/06/2002 | CN1378596A BASB 111 polypeptide and polynucleotide from moraxella cathraahalis |